Enzyme known for promoting cancer found to also protect healthy cells

The new study found that telomerase reactivates in normal adult cells at a critical point in the aging process. Just before cell death, a burst of telomerase buffers cells from the stresses of aging, slowing the process and reducing DNA damage that could lead to cancer. The study was published in the Proceedings of the National Academy of Sciences on September 2, 2019.

“This study reshapes the current understanding of telomerase’s function in normal cells,”said Kan Cao, senior author of the study and an associate professor of cell biology and molecular genetics at UMD. “Our work shows, for the first time, that there is a role for telomerase in adult cells beyond promoting tumor formation. We can now say that regulated activation of telomerase at a critical point in a cell’s life cycle serves an important function.”

Telomerase prevents the shortening of telomeres — a specialized DNA-protein structure at the end of a cell’s chromosomes that protect the chromosomes from damage. Telomerase plays a critical role during embryonic development and stem cell differentiation, when cells divide profusely. In normal adult cells, telomerase is turned off and telomeres shorten with every cell division until they reach a critical length. At critical telomere length, cells stop dividing and either die or experience DNA damage that could cause malignancies.

Before this new work, scientists thought that telomerase expression in most adult cells could only lead to unlimited cell division like that seen in cancerous tumors.

Cao and her colleagues suspected telomerase may have a function in adult cells when they observed dramatic differences in the laboratory among sibling mice with shortened telomeres. The mice were the progeny of wild-type mice and genetically modified mice that had been bred for many generations without the ability to produce telomerase. All the siblings had abnormally short telomeres, but the researchers found that mice that had not inherited the gene to produce telomerase from their wild-type parent exhibited shorter lifespans, progressive tissue atrophy and spontaneous cancers.

To understand what was going on, Cao and her colleagues compared the skin cells of the sibling mice and found that while both cell lines had comparably short telomeres, cells from telomerase-deficient mice stopped dividing sooner and had more malignant transformations than cells from siblings that produced telomerase.

What’s more, the researchers found that as skin cells from non-telomerase-deficient mice approached critical telomere length, they naturally produced a burst of telomerase, which slowed the process of telomere shortening and reduced the amount of DNA damage that could lead to cancer. According to Cao, these results suggest that telomerase expressed near the end of a cell’s lifespan softened the blow of aging and led to a more gradual cell death.

The researchers also found that reactivating the gene for expressing telomerase in the telomerase-deficient cells rescued them, prolonging their ability to divide and reducing DNA damage.

To see if what they observed in mice held true for humans, the team conducted laboratory studies on human skin cells. The researchers found that human cells also expressed telomerase as they approached critical telomere length. In addition, human skin cells that were unable to express telomerase reached critical telomere length more quickly and displayed significantly more DNA damage than those that did express telomerase.

Cao said that the next step for researchers is to find out how telomerase expression is turned on as cells approach critical telomere length and to explore the underlying mechanisms by which telomerase acts as a buffer against the stresses of shortening telomeres.

Top Articles

Parasitic worms cause cancer — and could help cure it

Billions worldwide are infected with tropical worms. Unsurprisingly, most of these people live in poor countries, kept poor by the effects of worm-related malnourishment. What may surprise many is that worms also cause the majority of cases of some cancers in these countries.

Read More

Phytochemicals: beyond vitamins

Phytochemicals are non-nutritive chemicals in plant foods that protect plants from microbial invasions and infections.

Read More

Targeting an RNA-binding protein to fight aging

Researchers have found that the RNA-binding protein PUM2 contributes to the accumulation of defective mitochondria, a key feature of the aging process. Targeting PUM2 in old animals protects against age-related mitochondrial dysfunction.

Read More

Latest News

AAN recommends people 65+ be screened yearly for memory problems

To help physicians provide the highest quality patient-centered neurologic care, the American Academy of Neurology (AAN) is recommending physicians measure how frequently they complete annual assessments of people age 65 and older for thinking and memory problems.

Read

New protocol to improve gene therapy tool production

A method to create a faster and lower cost alternative for a gene therapy tool.

Read

Kidney disease: Senescent cell burden is reduced in humans by senolytic drugs

In a small safety and feasibility clinical trial, researchers have demonstrated for the first time that senescent cells can be removed from the body using drugs termed ‘senolytics.’ The result was verified not only in analysis of blood but also in changes in skin and fat tissue senescent cell abundance.

Read

“Our bodies are our gardens - our wills are our gardeners.”

William Shakespeare